VeriMomVeriMom

ursoloyl tetrapeptide-37 hamilelikte güvenli mi?

No harmonised CLP classification, SCCS opinion, or CIR safety assessment was identified for ursoloyl tetrapeptide-37 and no peer‑reviewed reproductive toxicity studies were found indicating developmental or reproductive hazard. Mechanistic reproductive concerns (endocrine disruption, retinoid‑like activity, etc.) were not identified. Dermal exposure from cosmetics is likely low but measurable for a small peptide/triterpenoid conjugate, so exposure score is 1. (Sources searched: ECHA Annex VI/C&L, SCCS/CIR, PubMed, ECHA dossiers, PubChem, CosIng, EWG.)

İçerikler
ursoloyl tetrapeptide-37
BILINEN RISK YOK
93
/100
0

Related ingredients

Frequently asked questions

ursoloyl tetrapeptide-37 hamilelikte güvenli mi?
No harmonised CLP classification, SCCS opinion, or CIR safety assessment was identified for ursoloyl tetrapeptide-37 and no peer‑reviewed reproductive toxicity studies were found indicating developmental or reproductive hazard. Mechanistic reproductive concerns (endocrine disruption, retinoid‑like activity, etc.) were not identified. Dermal exposure from cosmetics is likely low but measurable for a small peptide/triterpenoid conjugate, so exposure score is 1. (Sources searched: ECHA Annex VI/C&L, SCCS/CIR, PubMed, ECHA dossiers, PubChem, CosIng, EWG.)
ursoloyl tetrapeptide-37 emzirirken güvenli mi?
No data indicating lactation/breast‑milk transfer or adverse effects in nursing infants. No mechanistic data suggesting accumulation in milk. Dermal exposure from cosmetics is likely low but measurable, so exposure scored 1.
ursoloyl tetrapeptide-37 bebek cildi için güvenli mi?
No infant‑specific toxicity data were identified. Given measurable dermal absorption in adults (scored 1) and the higher surface‑area‑to‑weight and immature barrier in infants 0–3 y, exposure is increased by +1 per instructions to e=2. No evidence was found to increase hazard or mechanism scores for infants.
VeriMom ursoloyl tetrapeptide-37 nasıl puanlıyor?
VeriMom ursoloyl tetrapeptide-37'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
Hamilelikte ursoloyl tetrapeptide-37 yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin